Skip to main content

and
  1. Article

    Open Access

    Ningetinib, a novel FLT3 inhibitor, overcomes secondary drug resistance in acute myeloid leukemia

    FMS-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD) is a common mutation type in acute myeloid leukemia (AML) and is usually associated with poor patient prognosis. With advancements in molecular...

    Chuhong Hu, Yvyin Zhang, Jie Yang, Yanli Xu in Cell Communication and Signaling (2024)

  2. Article

    Open Access

    FBI-1 enhanced the resistance of triple-negative breast cancer cells to chemotherapeutic agents via the miR-30c/PXR axis

    The factor that binds to the inducer of short transcripts‐1 (FBI-1) is a transcription suppressor and an important proto‐oncogene that plays multiple roles in carcinogenesis and therapeutic resistance. In the ...

    Hua Yang, Lili Ren, Yanan Wang, Xuebing Bi, **aoli Li, Ming Wen in Cell Death & Disease (2020)